Successful use of omalizumab for prevention of fire ant anaphylaxis.
Tartibi
Hana M
HM
Majmundar
Amee R
AR
Khan
David A
DA
D000328:Adult; D000707:Anaphylaxis / Q000517:prevention & control* / Q000628:therapy*; D000818:Animals; D018926:Anti-Allergic Agents / Q000494:pharmacology; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D001000:Ants; D003888:Desensitization, Immunologic / Q000379:methods; D005260:Female; D006801:Humans; D000069444:Omalizumab
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab